Skip to main content
OpenTrials

Clinical trial condition

Acute Myelogenous Leukemia

Explore clinical trials studying Acute Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

154 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Acute Myelogenous Leukemia trial results

Completed

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

NCT00064584

Conditions
Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details
Completed

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

NCT00116467

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT04904588

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +30 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 39 locations
View Trial Details

Related conditions